Opportunities in the lung cancer antibody drug conjugates market include developing specific, low-toxicity therapies using ADCs, capitalizing on technology platforms like DXd, leveraging collaboration ...

Phase III results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj. Multi-dose, demonstrate that it ...

Merck and Cidara Therapeutics, Inc., have entered into a definitive agreement under which Merck will acquire Cidara for $9.2 ...

The addition of neoadjuvant trastuzumab deruxtecan (T-DXd; Enhertu) significantly improved pathologic complete response (pCR) ...

In a significant move to bolster its portfolio, Merck has announced its acquisition of Cidara Therapeutics for nearly $9.2 billion. This deal, which aims to secure access to an ex ...

Hepatitis A's effective, indigenous vaccine warrants urgent inclusion in India's Universal Immunisation Programme.

The vaccine effectiveness of PCV20 against IPD and all-cause pneumonia was highest among individuals aged 65 to 74 years and decreased with increasing age.

PATH and EuBiologics Co., LTD are pleased to announce Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.® ...

India must prioritize including the typhoid conjugate vaccine in its immunization program to combat the disease's high burden.

AstraZeneca has ended work on one of its potential drugs for fatty liver disease after viewing disappointing data from a ...

Presented robust CRB-701 clinical data at ESMO 2025 - 3.6 mg/kg dose generated ORR of 47.6% in HNSCC, 37.5% in cervical ...

The Doodle shows how the parabola changes with different numbers, making learning math fun and interactive for students.,, ...